About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
This a model from the article: A dynamical perspective of CTL cross-priming and regulation: implications forcancer immunology. It can be used to explore systemsbiology wodarz2003 cytotoxic t lymphocyte cross dynamics and compare simulation behavior across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "initial_a_star",
"label": "Initial A Star",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.initial_a_star",
"description": "Source state initial condition exposed as a model-specific control because no explicit intervention parameter is identifiable. Maps to SBML symbol `A_star`."
},
{
"name": "initial_model_state_t",
"label": "Initial Model State T",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.initial_model_state_t",
"description": "Source state initial condition exposed as a model-specific control because no explicit intervention parameter is identifiable. Maps to SBML symbol `T`."
},
{
"name": "initial_model_state_c",
"label": "Initial Model State C",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.initial_model_state_c",
"description": "Source state initial condition exposed as a model-specific control because no explicit intervention parameter is identifiable. Maps to SBML symbol `C`."
},
{
"name": "initial_model_state_a",
"label": "Initial Model State A",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.initial_model_state_a",
"description": "Source state initial condition exposed as a model-specific control because no explicit intervention parameter is identifiable. Maps to SBML symbol `A`."
}
],
"outputs": [
{
"name": "state",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.state"
},
{
"name": "summary",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.summary"
},
{
"name": "species_labels",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.species_labels"
},
{
"name": "a_star",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.a_star"
},
{
"name": "model_state_t",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.model_state_t"
},
{
"name": "model_state_c",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.model_state_c"
},
{
"name": "model_state_a",
"maps_to": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.model_state_a"
}
]
},
"tags": [
"immunology",
"oncology",
"systemsbiology",
"sbml",
"biomodels_ebi",
"faithful",
"curated"
],
"title": "Wodarz2003 Cytotoxic T Lymphocyte Cross Priming Lab",
"models": [
{
"path": "models/core",
"alias": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model_state"
],
"from": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.state"
},
{
"to": [
"visualisation.systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model_summary"
],
"from": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.summary"
},
{
"to": [
"visualisation.systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model_species_labels"
],
"from": "systemsbiology_sbml_wodarz2003_cytotoxic_t_lymphocyte_cross_priming_biomd0000000685_model.species_labels"
}
],
"package": "wodarz2003-cytotoxic-t-lymphocyte-cross-priming",
"runtime": {
"duration": 1,
"initial_inputs": {},
"communication_step": 0.1
},
"version": "1.0.0",
"description": "This a model from the article: A dynamical perspective of CTL cross-priming and regulation: implications forcancer immunology. It can be used to explore systemsbiology wodarz2003 cytotoxic t lymphocyte cross dynamics and compare simulation behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration1
Comms Step0.1
Runs
Total0
Completed0
Failed0
Metadata
Packagewodarz2003-cytotoxic-t-lymphocyte-cross-priming
Created2026-05-17
Updated2026-06-13
immunologyoncologysystemsbiologysbmlbiomodels_ebifaithfulcuratedvisualisationother